CD4 and HIV-1 infection: Long-term use of cART during chronic HIV-1 infection may increase numbers of memory and naïve CD4 T cells specific for opportunistic pathogens, but does not apparently allow regeneration of proliferative HIV-1-specific CD4 T-cell responses with the potential to keep the virus under control (Autran et al., 1997).